Gait impairments are among the most common and disabling symptoms of Parkinson's
disease. Nonetheless, gait is not routinely assessed quantitatively but is described in …

Mobile health technologies (wearable, portable, body-fixed sensors, or domestic-integrated
devices) that quantify mobility in unsupervised, daily living environments are emerging as …

Introduction The aim of the present review is to track the evolution of wearable IMUs from
their use in supervised laboratory-and ambulatory-based settings to their application for long …

Objective Quantification of gait with wearable technology is promising; recent cross‐
sectional studies showed that gait characteristics are potential prodromal markers for …

Background The traditional evaluation of gait in the laboratory during structured testing has
provided important insights, but is limited by its “snapshot” character and observation in an …

Gait assessment is an essential tool for clinical applications not only to diagnose different
neurological conditions but also to monitor disease progression as it contributes to the …

With disease-modifying drugs on the horizon for degenerative ataxias, ecologically valid,
finely granulated, digital health measures are highly warranted to augment clinical and …

Physical mobility is essential to health, and patients often rate it as a high-priority clinical
outcome. Digital mobility outcomes (DMOs), such as real-world gait speed or step count …

Parkinson's disease (PD) is a progressive neurological disorder of the central nervous
system that deteriorates motor functions, while it is also accompanied by a large diversity of …

The increasing prevalence of neurodegenerative conditions such as Parkinson's disease
(PD) and related mobility issues places a serious burden on healthcare systems. The COVID …